nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR1D—autistic disorder	0.385	0.526	CbGaD
Methysergide—HTR1B—autistic disorder	0.228	0.312	CbGaD
Methysergide—HTR2A—autistic disorder	0.119	0.162	CbGaD
Methysergide—HTR1B—telencephalic ventricle—autistic disorder	0.00407	0.0403	CbGeAlD
Methysergide—HTR1D—telencephalic ventricle—autistic disorder	0.00394	0.039	CbGeAlD
Methysergide—HTR2C—telencephalic ventricle—autistic disorder	0.0039	0.0386	CbGeAlD
Methysergide—HTR7—pons—autistic disorder	0.00381	0.0378	CbGeAlD
Methysergide—HTR2A—cerebellar cortex—autistic disorder	0.00336	0.0333	CbGeAlD
Methysergide—HTR1A—telencephalic ventricle—autistic disorder	0.00328	0.0325	CbGeAlD
Methysergide—HTR7—telencephalic ventricle—autistic disorder	0.00314	0.0311	CbGeAlD
Methysergide—HTR1F—forebrain—autistic disorder	0.00259	0.0257	CbGeAlD
Methysergide—HTR1F—telencephalon—autistic disorder	0.00238	0.0236	CbGeAlD
Methysergide—HTR2A—pons—autistic disorder	0.00238	0.0235	CbGeAlD
Methysergide—HTR1E—brainstem—autistic disorder	0.00233	0.023	CbGeAlD
Methysergide—HTR1E—forebrain—autistic disorder	0.00224	0.0222	CbGeAlD
Methysergide—HTR1E—telencephalon—autistic disorder	0.00206	0.0205	CbGeAlD
Methysergide—HTR2A—telencephalic ventricle—autistic disorder	0.00196	0.0194	CbGeAlD
Methysergide—HTR6—forebrain—autistic disorder	0.00176	0.0175	CbGeAlD
Methysergide—HTR6—telencephalon—autistic disorder	0.00162	0.016	CbGeAlD
Methysergide—HTR1A—hindbrain—autistic disorder	0.00155	0.0153	CbGeAlD
Methysergide—HTR1F—head—autistic disorder	0.00148	0.0147	CbGeAlD
Methysergide—HTR7—hindbrain—autistic disorder	0.00148	0.0147	CbGeAlD
Methysergide—HTR1F—nervous system—autistic disorder	0.00141	0.0139	CbGeAlD
Methysergide—HTR1F—central nervous system—autistic disorder	0.00135	0.0134	CbGeAlD
Methysergide—HTR7—mouth—autistic disorder	0.0013	0.0129	CbGeAlD
Methysergide—HTR1E—head—autistic disorder	0.00129	0.0127	CbGeAlD
Methysergide—HTR1E—nervous system—autistic disorder	0.00122	0.0121	CbGeAlD
Methysergide—HTR1E—central nervous system—autistic disorder	0.00117	0.0116	CbGeAlD
Methysergide—HTR1B—brainstem—autistic disorder	0.0011	0.0109	CbGeAlD
Methysergide—HTR1F—brain—autistic disorder	0.00108	0.0107	CbGeAlD
Methysergide—HTR1D—brainstem—autistic disorder	0.00106	0.0106	CbGeAlD
Methysergide—HTR1B—forebrain—autistic disorder	0.00106	0.0105	CbGeAlD
Methysergide—HTR2C—brainstem—autistic disorder	0.00105	0.0104	CbGeAlD
Methysergide—HTR1D—eye—autistic disorder	0.00104	0.0103	CbGeAlD
Methysergide—HTR1D—forebrain—autistic disorder	0.00103	0.0102	CbGeAlD
Methysergide—HTR2C—forebrain—autistic disorder	0.00102	0.0101	CbGeAlD
Methysergide—HTR6—head—autistic disorder	0.00101	0.00999	CbGeAlD
Methysergide—HTR1B—telencephalon—autistic disorder	0.000976	0.00967	CbGeAlD
Methysergide—SIGMAR1—eye—autistic disorder	0.000967	0.00958	CbGeAlD
Methysergide—HTR6—nervous system—autistic disorder	0.000956	0.00947	CbGeAlD
Methysergide—HTR2B—forebrain—autistic disorder	0.000956	0.00947	CbGeAlD
Methysergide—HTR1D—telencephalon—autistic disorder	0.000945	0.00936	CbGeAlD
Methysergide—HTR2C—telencephalon—autistic disorder	0.000936	0.00927	CbGeAlD
Methysergide—HTR1E—brain—autistic disorder	0.000931	0.00923	CbGeAlD
Methysergide—HTR2A—hindbrain—autistic disorder	0.000923	0.00915	CbGeAlD
Methysergide—HTR6—central nervous system—autistic disorder	0.000921	0.00912	CbGeAlD
Methysergide—HTR1A—brainstem—autistic disorder	0.000888	0.0088	CbGeAlD
Methysergide—SIGMAR1—telencephalon—autistic disorder	0.000881	0.00873	CbGeAlD
Methysergide—HTR2B—telencephalon—autistic disorder	0.000879	0.00871	CbGeAlD
Methysergide—HTR1A—forebrain—autistic disorder	0.000857	0.00849	CbGeAlD
Methysergide—HTR7—brainstem—autistic disorder	0.000848	0.00841	CbGeAlD
Methysergide—HTR7—forebrain—autistic disorder	0.000819	0.00811	CbGeAlD
Methysergide—HTR1A—telencephalon—autistic disorder	0.000788	0.00781	CbGeAlD
Methysergide—HTR7—telencephalon—autistic disorder	0.000753	0.00746	CbGeAlD
Methysergide—HTR6—brain—autistic disorder	0.000731	0.00724	CbGeAlD
Methysergide—Lisuride—HTR1D—autistic disorder	0.000709	0.111	CrCbGaD
Methysergide—Ergotamine—HTR1D—autistic disorder	0.000681	0.107	CrCbGaD
Methysergide—HTR2B—digestive system—autistic disorder	0.000671	0.00665	CbGeAlD
Methysergide—Bromocriptine—HTR1D—autistic disorder	0.000657	0.103	CrCbGaD
Methysergide—HTR1B—head—autistic disorder	0.000608	0.00602	CbGeAlD
Methysergide—Methylergometrine—DRD1—autistic disorder	0.000598	0.0937	CrCbGaD
Methysergide—HTR1D—head—autistic disorder	0.000589	0.00583	CbGeAlD
Methysergide—HTR2C—head—autistic disorder	0.000583	0.00577	CbGeAlD
Methysergide—HTR1B—nervous system—autistic disorder	0.000576	0.00571	CbGeAlD
Methysergide—HTR7—digestive system—autistic disorder	0.000575	0.00569	CbGeAlD
Methysergide—HTR1D—nervous system—autistic disorder	0.000558	0.00553	CbGeAlD
Methysergide—HTR1B—central nervous system—autistic disorder	0.000555	0.0055	CbGeAlD
Methysergide—HTR2C—nervous system—autistic disorder	0.000553	0.00547	CbGeAlD
Methysergide—HTR2B—head—autistic disorder	0.000547	0.00542	CbGeAlD
Methysergide—HTR1D—central nervous system—autistic disorder	0.000537	0.00532	CbGeAlD
Methysergide—HTR2C—central nervous system—autistic disorder	0.000532	0.00527	CbGeAlD
Methysergide—HTR2A—brainstem—autistic disorder	0.000529	0.00524	CbGeAlD
Methysergide—HTR2B—nervous system—autistic disorder	0.000519	0.00514	CbGeAlD
Methysergide—HTR2A—eye—autistic disorder	0.000515	0.0051	CbGeAlD
Methysergide—HTR2A—forebrain—autistic disorder	0.000511	0.00506	CbGeAlD
Methysergide—HTR2B—central nervous system—autistic disorder	0.0005	0.00495	CbGeAlD
Methysergide—HTR1A—head—autistic disorder	0.000491	0.00486	CbGeAlD
Methysergide—SIGMAR1—cerebellum—autistic disorder	0.00049	0.00485	CbGeAlD
Methysergide—HTR2A—telencephalon—autistic disorder	0.000469	0.00465	CbGeAlD
Methysergide—HTR7—head—autistic disorder	0.000469	0.00465	CbGeAlD
Methysergide—HTR1A—nervous system—autistic disorder	0.000465	0.00461	CbGeAlD
Methysergide—HTR1A—central nervous system—autistic disorder	0.000448	0.00444	CbGeAlD
Methysergide—HTR7—nervous system—autistic disorder	0.000444	0.0044	CbGeAlD
Methysergide—HTR1B—brain—autistic disorder	0.000441	0.00436	CbGeAlD
Methysergide—HTR1A—cerebellum—autistic disorder	0.000438	0.00434	CbGeAlD
Methysergide—HTR7—central nervous system—autistic disorder	0.000428	0.00424	CbGeAlD
Methysergide—HTR1D—brain—autistic disorder	0.000426	0.00423	CbGeAlD
Methysergide—HTR2C—brain—autistic disorder	0.000422	0.00418	CbGeAlD
Methysergide—Lisuride—HTR1B—autistic disorder	0.000421	0.066	CrCbGaD
Methysergide—HTR7—cerebellum—autistic disorder	0.000418	0.00414	CbGeAlD
Methysergide—Lisuride—DRD3—autistic disorder	0.000408	0.064	CrCbGaD
Methysergide—Ergotamine—HTR1B—autistic disorder	0.000404	0.0634	CrCbGaD
Methysergide—Lisuride—DRD1—autistic disorder	0.000401	0.0629	CrCbGaD
Methysergide—SIGMAR1—brain—autistic disorder	0.000398	0.00394	CbGeAlD
Methysergide—HTR2B—brain—autistic disorder	0.000397	0.00393	CbGeAlD
Methysergide—Bromocriptine—HTR1B—autistic disorder	0.00039	0.0611	CrCbGaD
Methysergide—Bromocriptine—DRD3—autistic disorder	0.000378	0.0593	CrCbGaD
Methysergide—Bromocriptine—DRD1—autistic disorder	0.000371	0.0582	CrCbGaD
Methysergide—HTR2A—digestive system—autistic disorder	0.000358	0.00355	CbGeAlD
Methysergide—HTR1A—brain—autistic disorder	0.000355	0.00352	CbGeAlD
Methysergide—HTR7—brain—autistic disorder	0.00034	0.00337	CbGeAlD
Methysergide—Methylergometrine—HTR2A—autistic disorder	0.000326	0.0511	CrCbGaD
Methysergide—HTR2A—head—autistic disorder	0.000292	0.0029	CbGeAlD
Methysergide—HTR2A—nervous system—autistic disorder	0.000277	0.00275	CbGeAlD
Methysergide—HTR2A—central nervous system—autistic disorder	0.000267	0.00264	CbGeAlD
Methysergide—HTR2A—cerebellum—autistic disorder	0.000261	0.00258	CbGeAlD
Methysergide—Lisuride—HTR2A—autistic disorder	0.000218	0.0342	CrCbGaD
Methysergide—HTR2A—brain—autistic disorder	0.000212	0.0021	CbGeAlD
Methysergide—Ergotamine—HTR2A—autistic disorder	0.00021	0.0329	CrCbGaD
Methysergide—Bromocriptine—HTR2A—autistic disorder	0.000202	0.0317	CrCbGaD
Methysergide—HTR2C—GPCR downstream signaling—PIK3CG—autistic disorder	9.07e-06	5.64e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IL5—autistic disorder	9.01e-06	5.6e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IL5—autistic disorder	8.96e-06	5.57e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—SERPINE1—autistic disorder	8.92e-06	5.55e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CALCA—autistic disorder	8.9e-06	5.53e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PLA2G4A—autistic disorder	8.9e-06	5.53e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PLA2G4A—autistic disorder	8.89e-06	5.53e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IGF1—autistic disorder	8.86e-06	5.51e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CALCA—autistic disorder	8.85e-06	5.51e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PLA2G4A—autistic disorder	8.83e-06	5.49e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—OXT—autistic disorder	8.83e-06	5.49e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—HTR1B—autistic disorder	8.83e-06	5.49e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—MAPK1—autistic disorder	8.81e-06	5.48e-05	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—POMC—autistic disorder	8.68e-06	5.4e-05	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—IL2—autistic disorder	8.67e-06	5.39e-05	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—IL2—autistic disorder	8.66e-06	5.39e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MEF2C—autistic disorder	8.66e-06	5.38e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—PRKCB—autistic disorder	8.65e-06	5.38e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PLA2G4A—autistic disorder	8.65e-06	5.38e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MEF2C—autistic disorder	8.65e-06	5.38e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—AVP—autistic disorder	8.64e-06	5.37e-05	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—POMC—autistic disorder	8.63e-06	5.37e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—PRKCB—autistic disorder	8.61e-06	5.35e-05	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—IL2—autistic disorder	8.6e-06	5.35e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IGF2—autistic disorder	8.6e-06	5.35e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MEF2C—autistic disorder	8.59e-06	5.34e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—ITGB3—autistic disorder	8.44e-06	5.25e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—ITGB3—autistic disorder	8.43e-06	5.24e-05	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—IL2—autistic disorder	8.42e-06	5.24e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MEF2C—autistic disorder	8.41e-06	5.23e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—SERPINE1—autistic disorder	8.41e-06	5.23e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—ITGB3—autistic disorder	8.37e-06	5.21e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—PIK3CG—autistic disorder	8.28e-06	5.15e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—PIK3CG—autistic disorder	8.24e-06	5.12e-05	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—PRKCB—autistic disorder	8.23e-06	5.12e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TSC1—autistic disorder	8.21e-06	5.11e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—DRD1—autistic disorder	8.21e-06	5.11e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—ITGB3—autistic disorder	8.2e-06	5.1e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PLA2G4A—autistic disorder	8.12e-06	5.05e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NTRK2—autistic disorder	7.99e-06	4.97e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—DRD3—autistic disorder	7.95e-06	4.95e-05	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—IL2—autistic disorder	7.91e-06	4.92e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MEF2C—autistic disorder	7.9e-06	4.91e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—POMC—autistic disorder	7.88e-06	4.9e-05	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—PIK3CG—autistic disorder	7.88e-06	4.9e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—HTR2A—autistic disorder	7.88e-06	4.9e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—IL2—autistic disorder	7.87e-06	4.9e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—HTR2A—autistic disorder	7.87e-06	4.89e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—IL2—autistic disorder	7.86e-06	4.89e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PRL—autistic disorder	7.86e-06	4.89e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—POMC—autistic disorder	7.84e-06	4.88e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PRL—autistic disorder	7.82e-06	4.86e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—HTR2A—autistic disorder	7.82e-06	4.86e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—IL2—autistic disorder	7.81e-06	4.86e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IL5—autistic disorder	7.78e-06	4.84e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—ITGB3—autistic disorder	7.7e-06	4.79e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CALCA—autistic disorder	7.69e-06	4.78e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—HTR2A—autistic disorder	7.65e-06	4.76e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—IL2—autistic disorder	7.65e-06	4.76e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—HRAS—autistic disorder	7.5e-06	4.67e-05	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—POMC—autistic disorder	7.5e-06	4.66e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TSC2—autistic disorder	7.48e-06	4.65e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—PRKCB—autistic disorder	7.47e-06	4.65e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TSC2—autistic disorder	7.47e-06	4.65e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ADRB2—autistic disorder	7.46e-06	4.64e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TSC2—autistic disorder	7.42e-06	4.62e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ADRB2—autistic disorder	7.42e-06	4.61e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—APOE—autistic disorder	7.32e-06	4.55e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—LEP—autistic disorder	7.32e-06	4.55e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—APOE—autistic disorder	7.31e-06	4.55e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—LEP—autistic disorder	7.31e-06	4.55e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TSC2—autistic disorder	7.27e-06	4.52e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—APOE—autistic disorder	7.27e-06	4.52e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—LEP—autistic disorder	7.27e-06	4.52e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IL2—autistic disorder	7.22e-06	4.49e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—HTR2A—autistic disorder	7.19e-06	4.47e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—IL2—autistic disorder	7.19e-06	4.47e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—IL6—autistic disorder	7.18e-06	4.47e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—PIK3CG—autistic disorder	7.15e-06	4.45e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—APOE—autistic disorder	7.11e-06	4.43e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—LEP—autistic disorder	7.11e-06	4.43e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—HRAS—autistic disorder	7.08e-06	4.4e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—AVP—autistic disorder	7.01e-06	4.36e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IGF2—autistic disorder	6.98e-06	4.34e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—AVP—autistic disorder	6.97e-06	4.34e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IGF2—autistic disorder	6.94e-06	4.32e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PRKCB—autistic disorder	6.9e-06	4.29e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PRKCB—autistic disorder	6.9e-06	4.29e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PRKCB—autistic disorder	6.85e-06	4.26e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TSC2—autistic disorder	6.83e-06	4.25e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—POMC—autistic disorder	6.81e-06	4.23e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IL2—autistic disorder	6.81e-06	4.23e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PRL—autistic disorder	6.79e-06	4.22e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—PTEN—autistic disorder	6.79e-06	4.22e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—IL6—autistic disorder	6.77e-06	4.21e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PRKCB—autistic disorder	6.71e-06	4.17e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—APOE—autistic disorder	6.68e-06	4.16e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—LEP—autistic disorder	6.68e-06	4.16e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—APC—autistic disorder	6.61e-06	4.11e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PIK3CG—autistic disorder	6.61e-06	4.11e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PIK3CG—autistic disorder	6.6e-06	4.11e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—APC—autistic disorder	6.6e-06	4.11e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PLA2G4A—autistic disorder	6.59e-06	4.1e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—APC—autistic disorder	6.56e-06	4.08e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PIK3CG—autistic disorder	6.56e-06	4.08e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PLA2G4A—autistic disorder	6.55e-06	4.08e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—EGF—autistic disorder	6.53e-06	4.06e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—EGF—autistic disorder	6.52e-06	4.06e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—EGF—autistic disorder	6.48e-06	4.03e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ADRB2—autistic disorder	6.44e-06	4.01e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PIK3CG—autistic disorder	6.42e-06	3.99e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—APC—autistic disorder	6.42e-06	3.99e-05	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—IL2—autistic disorder	6.42e-06	3.99e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MEF2C—autistic disorder	6.41e-06	3.99e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—PTEN—autistic disorder	6.4e-06	3.98e-05	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—IL2—autistic disorder	6.38e-06	3.97e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MEF2C—autistic disorder	6.38e-06	3.97e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—EGF—autistic disorder	6.35e-06	3.95e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PRKCB—autistic disorder	6.3e-06	3.92e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—POMC—autistic disorder	6.29e-06	3.91e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—POMC—autistic disorder	6.28e-06	3.91e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ITGB3—autistic disorder	6.24e-06	3.88e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—POMC—autistic disorder	6.24e-06	3.88e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ITGB3—autistic disorder	6.21e-06	3.86e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—POMC—autistic disorder	6.11e-06	3.8e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AVP—autistic disorder	6.05e-06	3.76e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IGF1—autistic disorder	6.05e-06	3.76e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IGF1—autistic disorder	6.04e-06	3.76e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PIK3CG—autistic disorder	6.03e-06	3.75e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—APC—autistic disorder	6.03e-06	3.75e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IGF2—autistic disorder	6.03e-06	3.75e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—MAPK1—autistic disorder	6.02e-06	3.75e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—MAPK1—autistic disorder	6.01e-06	3.74e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IGF1—autistic disorder	6e-06	3.73e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—MAPK1—autistic disorder	5.98e-06	3.72e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—EGF—autistic disorder	5.96e-06	3.71e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IGF1—autistic disorder	5.88e-06	3.66e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—MAPK1—autistic disorder	5.85e-06	3.64e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—HTR2A—autistic disorder	5.83e-06	3.63e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—IL2—autistic disorder	5.83e-06	3.62e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HTR2A—autistic disorder	5.8e-06	3.61e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—IL2—autistic disorder	5.8e-06	3.61e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—SERPINE1—autistic disorder	5.75e-06	3.57e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—POMC—autistic disorder	5.74e-06	3.57e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—SERPINE1—autistic disorder	5.74e-06	3.57e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—SERPINE1—autistic disorder	5.7e-06	3.55e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PLA2G4A—autistic disorder	5.69e-06	3.54e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—SERPINE1—autistic disorder	5.58e-06	3.47e-05	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—IL2—autistic disorder	5.54e-06	3.45e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TSC2—autistic disorder	5.54e-06	3.44e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MEF2C—autistic disorder	5.54e-06	3.44e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IGF1—autistic disorder	5.52e-06	3.43e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—MAPK1—autistic disorder	5.52e-06	3.43e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TSC2—autistic disorder	5.51e-06	3.43e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—MAPK1—autistic disorder	5.5e-06	3.42e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—APOE—autistic disorder	5.42e-06	3.37e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—LEP—autistic disorder	5.42e-06	3.37e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ITGB3—autistic disorder	5.39e-06	3.36e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—APOE—autistic disorder	5.39e-06	3.35e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—LEP—autistic disorder	5.39e-06	3.35e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SERPINE1—autistic disorder	5.24e-06	3.26e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—MAPK1—autistic disorder	5.21e-06	3.24e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PRKCB—autistic disorder	5.11e-06	3.18e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PRKCB—autistic disorder	5.08e-06	3.16e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—IL2—autistic disorder	5.03e-06	3.13e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—APC—autistic disorder	4.89e-06	3.04e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PIK3CG—autistic disorder	4.89e-06	3.04e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—APC—autistic disorder	4.87e-06	3.03e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PIK3CG—autistic disorder	4.87e-06	3.03e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—EGF—autistic disorder	4.83e-06	3.01e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—HRAS—autistic disorder	4.83e-06	3.01e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—HRAS—autistic disorder	4.83e-06	3e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—EGF—autistic disorder	4.81e-06	2.99e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—HRAS—autistic disorder	4.8e-06	2.98e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TSC2—autistic disorder	4.78e-06	2.98e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—HRAS—autistic disorder	4.7e-06	2.92e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—LEP—autistic disorder	4.68e-06	2.91e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—APOE—autistic disorder	4.68e-06	2.91e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—POMC—autistic disorder	4.66e-06	2.9e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IL2—autistic disorder	4.65e-06	2.89e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IL2—autistic disorder	4.64e-06	2.89e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—POMC—autistic disorder	4.63e-06	2.88e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—IL6—autistic disorder	4.63e-06	2.88e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—IL6—autistic disorder	4.62e-06	2.87e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IL2—autistic disorder	4.61e-06	2.87e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—IL6—autistic disorder	4.59e-06	2.86e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IL2—autistic disorder	4.52e-06	2.81e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—IL6—autistic disorder	4.5e-06	2.8e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IGF1—autistic disorder	4.48e-06	2.79e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—MAPK1—autistic disorder	4.46e-06	2.77e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IGF1—autistic disorder	4.46e-06	2.77e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—MAPK1—autistic disorder	4.43e-06	2.76e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—HRAS—autistic disorder	4.43e-06	2.76e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PRKCB—autistic disorder	4.42e-06	2.75e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—HRAS—autistic disorder	4.41e-06	2.74e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PTEN—autistic disorder	4.38e-06	2.72e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PTEN—autistic disorder	4.37e-06	2.72e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PTEN—autistic disorder	4.34e-06	2.7e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SERPINE1—autistic disorder	4.25e-06	2.65e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PTEN—autistic disorder	4.25e-06	2.64e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IL2—autistic disorder	4.24e-06	2.64e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IL6—autistic disorder	4.24e-06	2.64e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SERPINE1—autistic disorder	4.23e-06	2.63e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—APC—autistic disorder	4.23e-06	2.63e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PIK3CG—autistic disorder	4.23e-06	2.63e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—IL6—autistic disorder	4.22e-06	2.63e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—HRAS—autistic disorder	4.18e-06	2.6e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—EGF—autistic disorder	4.18e-06	2.6e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—POMC—autistic disorder	4.02e-06	2.5e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IL6—autistic disorder	4e-06	2.49e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PTEN—autistic disorder	3.99e-06	2.48e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IGF1—autistic disorder	3.87e-06	2.41e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—MAPK1—autistic disorder	3.85e-06	2.39e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SERPINE1—autistic disorder	3.67e-06	2.29e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—HRAS—autistic disorder	3.58e-06	2.23e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—HRAS—autistic disorder	3.56e-06	2.21e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MAPK1—autistic disorder	3.56e-06	2.21e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MAPK1—autistic disorder	3.55e-06	2.21e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MAPK1—autistic disorder	3.53e-06	2.2e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MAPK1—autistic disorder	3.46e-06	2.15e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IL2—autistic disorder	3.44e-06	2.14e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—IL6—autistic disorder	3.42e-06	2.13e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IL2—autistic disorder	3.42e-06	2.13e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—IL6—autistic disorder	3.41e-06	2.12e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MAPK1—autistic disorder	3.25e-06	2.02e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PTEN—autistic disorder	3.24e-06	2.01e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PTEN—autistic disorder	3.22e-06	2e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—HRAS—autistic disorder	3.09e-06	1.92e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IL2—autistic disorder	2.97e-06	1.85e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—IL6—autistic disorder	2.96e-06	1.84e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—HRAS—autistic disorder	2.86e-06	1.78e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—HRAS—autistic disorder	2.85e-06	1.77e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—HRAS—autistic disorder	2.83e-06	1.76e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PTEN—autistic disorder	2.8e-06	1.74e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—HRAS—autistic disorder	2.77e-06	1.73e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IL6—autistic disorder	2.73e-06	1.7e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IL6—autistic disorder	2.73e-06	1.7e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IL6—autistic disorder	2.71e-06	1.69e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IL6—autistic disorder	2.66e-06	1.65e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MAPK1—autistic disorder	2.63e-06	1.64e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MAPK1—autistic disorder	2.62e-06	1.63e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—HRAS—autistic disorder	2.61e-06	1.62e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IL6—autistic disorder	2.49e-06	1.55e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MAPK1—autistic disorder	2.27e-06	1.41e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—HRAS—autistic disorder	2.11e-06	1.31e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HRAS—autistic disorder	2.1e-06	1.31e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IL6—autistic disorder	2.02e-06	1.26e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IL6—autistic disorder	2.01e-06	1.25e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—HRAS—autistic disorder	1.83e-06	1.14e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IL6—autistic disorder	1.75e-06	1.09e-05	CbGpPWpGaD
